PitchBook News - Sizing up the 2022 IPO market

Read online | Don't want to receive these emails? Manage your subscription.

PitchBook

Log in

The Daily Pitch: VC

January 3, 2022

Like our newsletter? The data comes from the PitchBook Platform — our data software for VC, PE and M&A

In today's Daily Pitch, you'll find:

A decade-long buildup of VC-backed startups promises a busy US IPO market in 2022.

PitchBook analysts predict a big year in 2022 for US private equity.

From 'solo VCs' to the rise of climate tech, our most-read articles of 2021.

Today's Top Stories

Analysts forecast a huge 2022 for US PE

(Nora Carol Photography/Getty Images)

The AUM of the big five public alternatives managers will eclipse $3 trillion this year. Funds over $5 billion will collectively raise $250 billion, including the three largest-ever buyout funds. And PE firms will close at least 400 middle-market software deals.

These are just a few of the forecasts that PitchBook analysts made for private equity this year. Our Private Equity Outlook details seven predictions in US PE, including a big IPO year for private capital managers and new exit opportunities for PE-backed healthcare provider platforms.

read it now

Share:

What to watch for in the 2022 IPO market

(Andriy Onufriyenko/Getty Images)

After a standout year for public listings that padded the pockets of investors, the US IPO market has entered 2022 from a position of strength. Household names like Reddit and Chobani are lining up offerings, and a large volume of IPO-ready companies should keep the supply coming.

But there are headwinds—from rising interest rates to declining sentiment for IPOs and SPACs—that threaten the market's momentum.

Recommended Reads

How Tiger Global changed venture capital dealmaking in 2021. [Business Insider]

The EU hopes to classify some natural gas and nuclear power investments as climate-friendly. But what makes an investment "green"? [The Wall Street Journal]

After a year dominated by Mars and space tourism, companies and governments are turning their attention to the moon in 2022. [The New York Times]

Since yesterday, the PitchBook Platform added:

3

VC valuations

144

People

48

Companies

8

Funds

See what our data software can do

Quick Takes


	The Daily Benchmark
	2018 Vintage European PE Funds
	People
	Oak HC/FT promotes Chandramouli to partner
	VC Deals
	GenFleet Therapeutics raises $75M
	Voyant Photonics raises $15.4M Series A
	Amberstone Biosciences picks up $12M
	Curi Bio lands $10M Series A
	Exits & IPOs
	Energy Impact Partners pulls SPAC plans
	Delivery Hero takes over Spain's Glovo

The Daily Benchmark

2018 Vintage European PE Funds

Median IRR

20.75%

Top Quartile IRR

32.30%

1.15x

Median TVPI

Select top performers

TDR Capital IV

Nordic Capital Fund IX

V4C Poland Plus Fund

*IRR: net of fees

30 Funds in Benchmark »

Check out the latest version of PitchBook Benchmarks

People

Oak HC/FT promotes Chandramouli to partner

Oak HC/FT, a VC and growth equity firm that focuses on the fintech and healthtech sectors, has promoted Vig Chandramouli to partner. Chandramouli focuses on investing in healthcare companies.

View details

View 91 investments »

VC Deals

GenFleet Therapeutics raises $75M

GenFleet Therapeutics has raised a $75 million Series C led by Huagai Capital. Investors including Suxin Venture Capital, Cherami Investment Group, ABC International, DYEE Capital, Qiaojing Eastern Investment, Baidu Venture and Wenzhou Capital also participated. The Shanghai-based company develops treatments for cancer and autoimmune diseases.

View round

View 37 competitors »

Voyant Photonics raises $15.4M Series A

Voyant Photonics has raised $15.4 million in a round led by UP.Partners, with support from LDV Capital and Contour Ventures. The company is a developer of LiDAR systems fabricated on semiconductor chips.

View round

View similar company »

Amberstone Biosciences picks up $12M

Amberstone Biosciences has raised a $12 million Series A co-led by Viva BioInnovator, Co-win Ventures and Sinovation Ventures. Founded in 2018, the Laguna Hillls, Calif.-based company is a developer of immunotherapeutics intended to treat solid tumor cancers and other diseases.

Additional Investors:

Changrong Capital, Lifespan Investments

View round

View similar company »

Curi Bio lands $10M Series A

Curi Bio has raised $10 million from investors including Dynamk Capital and DS Asset Management. Based in Seattle, the company is a creator of human stem cell-based products designed to aid the development of genetic medicines and cell therapies.

Additional Investor:

UTC Investment

View round

View similar company »

Exits & IPOs

Energy Impact Partners pulls SPAC plans

ESG investor Energy Impact Partners has withdrawn its IPO registration for EIP Acquisition Corp I. The blank-check company was intended to target a business in the energy transition and decarbonization sector. EIP Acquisition had been seeking $300 million in its IPO.

View details

View similar company »

Delivery Hero takes over Spain's Glovo

Delivery Hero has agreed to acquire a 39.4% stake in Glovo, bringing its holdings in the Spanish delivery app provider to more than 83% and valuing Glove at €2.3 billion, Reuters reported. The Barcelona-based startup has raised funding from investors including Luxor Capital, Mubadala, Drake Enterprises, Idinvest Partners and Lakestar.

View details

View 36 competitors »